Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Votrient with or without Casodex in hormone refractory prostate cancer
NCT00486642Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2007
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in prostate cancer (PCa), sponsored by National Cancer Institute. Started Sep 2007; status: completed.
02
Drugs
pazopanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00486642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486642.